Not many North American companies want to be in the commodity chemicals
business anymore, and more and more of that business has migrated to
countries such as China, India and Brazil. So, like many other chemical
companies,
Cabot (NYSE:
CBT)
has worked hard to remake itself into more of a specialty chemical
company with differentiated products. Global sluggishness isn't helping
the business at the moment, and the combination of elevated debt and
historically unimpressive margins are risk factors, but changes in how
the company does business could lead to better long-term results.
Please click this link for more:
http://www.investopedia.com/stock-analysis/2012/Cabot---Higher-Risk-But-Greater-Opportunities-CBT-DD-CCC-GT1002.aspx
No comments:
Post a Comment